Winslow Capital Management’s Pfizer PFE Stock Holding History

Winslow Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-89	Closed	-$3K	–	100
2014 Q1	$3K	Buy	+89	New	+$2.65K	﹤0.01%	97

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Winslow Capital Management's PFE Position: Q2 2014 in Review

Winslow Capital Management sold out of Pfizer (PFE) in Q2 2014, closing a stake of 89 shares — an estimated $3K sold.

Winslow Capital Management first reported a position in PFE in Q1 2014 and held it in 1 quarter. The position peaked at $3K in Q1 2014. 1,747 funds tracked by Wall St. Rank hold PFE as of Q2 2014.

Winslow Capital Management reported no remaining Pfizer position as of Q2 2014 after selling out during the quarter.
Winslow Capital Management sold 89 Pfizer shares in Q2 2014, an estimated $3K.
Winslow Capital Management first reported a position in Pfizer in Q1 2014 and held it in 1 quarter.
Winslow Capital Management's Pfizer position peaked at $3K in Q1 2014.
1,747 funds tracked by Wall St. Rank held Pfizer as of Q2 2014.

Based on Winslow Capital Management's 13F filing for Q2 2014, filed 12 Aug 2014.